Global Injectable Drug Delivery Formulation Market Insights and Forecast to 2031

Report ID: 1564043 | Published Date: Sep 2024 | No. of Page: 89 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Injectable Drug Delivery Formulation Product Introduction
    1.2 Market by Type
        1.2.1 Global Injectable Drug Delivery Formulation Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Conventional Drug Delivery Formulations
        1.2.3 Novel Drug Delivery Formulations
        1.2.4 Long-acting Formulations
    1.3 Market by Application
        1.3.1 Global Injectable Drug Delivery Formulation Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Autoimmune Diseases
        1.3.3 Hormonal Disorders
        1.3.4 Oncology
        1.3.5 Orphan Diseases
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Injectable Drug Delivery Formulation Sales Estimates and Forecasts 2017-2028
    2.2 Global Injectable Drug Delivery Formulation Revenue Estimates and Forecasts 2017-2028
    2.3 Global Injectable Drug Delivery Formulation Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Injectable Drug Delivery Formulation Sales by Region
        2.4.1 Global Injectable Drug Delivery Formulation Sales by Region (2017-2022)
        2.4.2 Global Sales Injectable Drug Delivery Formulation by Region (2023-2028)
    2.5 Global Injectable Drug Delivery Formulation Revenue by Region
        2.5.1 Global Injectable Drug Delivery Formulation Revenue by Region (2017-2022)
        2.5.2 Global Injectable Drug Delivery Formulation Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Injectable Drug Delivery Formulation Sales by Manufacturers
        3.1.1 Global Top Injectable Drug Delivery Formulation Manufacturers by Sales (2017-2022)
        3.1.2 Global Injectable Drug Delivery Formulation Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Injectable Drug Delivery Formulation in 2021
    3.2 Global Injectable Drug Delivery Formulation Revenue by Manufacturers
        3.2.1 Global Injectable Drug Delivery Formulation Revenue by Manufacturers (2017-2022)
        3.2.2 Global Injectable Drug Delivery Formulation Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Injectable Drug Delivery Formulation Revenue in 2021
    3.3 Global Injectable Drug Delivery Formulation Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Injectable Drug Delivery Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Injectable Drug Delivery Formulation Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Injectable Drug Delivery Formulation Sales by Type
        4.1.1 Global Injectable Drug Delivery Formulation Historical Sales by Type (2017-2022)
        4.1.2 Global Injectable Drug Delivery Formulation Forecasted Sales by Type (2023-2028)
        4.1.3 Global Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2028)
    4.2 Global Injectable Drug Delivery Formulation Revenue by Type
        4.2.1 Global Injectable Drug Delivery Formulation Historical Revenue by Type (2017-2022)
        4.2.2 Global Injectable Drug Delivery Formulation Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2017-2028)
    4.3 Global Injectable Drug Delivery Formulation Price by Type
        4.3.1 Global Injectable Drug Delivery Formulation Price by Type (2017-2022)
        4.3.2 Global Injectable Drug Delivery Formulation Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Injectable Drug Delivery Formulation Sales by Application
        5.1.1 Global Injectable Drug Delivery Formulation Historical Sales by Application (2017-2022)
        5.1.2 Global Injectable Drug Delivery Formulation Forecasted Sales by Application (2023-2028)
        5.1.3 Global Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2028)
    5.2 Global Injectable Drug Delivery Formulation Revenue by Application
        5.2.1 Global Injectable Drug Delivery Formulation Historical Revenue by Application (2017-2022)
        5.2.2 Global Injectable Drug Delivery Formulation Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2017-2028)
    5.3 Global Injectable Drug Delivery Formulation Price by Application
        5.3.1 Global Injectable Drug Delivery Formulation Price by Application (2017-2022)
        5.3.2 Global Injectable Drug Delivery Formulation Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Injectable Drug Delivery Formulation Market Size by Type
        6.1.1 North America Injectable Drug Delivery Formulation Sales by Type (2017-2028)
        6.1.2 North America Injectable Drug Delivery Formulation Revenue by Type (2017-2028)
    6.2 North America Injectable Drug Delivery Formulation Market Size by Application
        6.2.1 North America Injectable Drug Delivery Formulation Sales by Application (2017-2028)
        6.2.2 North America Injectable Drug Delivery Formulation Revenue by Application (2017-2028)
    6.3 North America Injectable Drug Delivery Formulation Market Size by Country
        6.3.1 North America Injectable Drug Delivery Formulation Sales by Country (2017-2028)
        6.3.2 North America Injectable Drug Delivery Formulation Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Injectable Drug Delivery Formulation Market Size by Type
        7.1.1 Europe Injectable Drug Delivery Formulation Sales by Type (2017-2028)
        7.1.2 Europe Injectable Drug Delivery Formulation Revenue by Type (2017-2028)
    7.2 Europe Injectable Drug Delivery Formulation Market Size by Application
        7.2.1 Europe Injectable Drug Delivery Formulation Sales by Application (2017-2028)
        7.2.2 Europe Injectable Drug Delivery Formulation Revenue by Application (2017-2028)
    7.3 Europe Injectable Drug Delivery Formulation Market Size by Country
        7.3.1 Europe Injectable Drug Delivery Formulation Sales by Country (2017-2028)
        7.3.2 Europe Injectable Drug Delivery Formulation Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Injectable Drug Delivery Formulation Market Size by Type
        8.1.1 Asia Pacific Injectable Drug Delivery Formulation Sales by Type (2017-2028)
        8.1.2 Asia Pacific Injectable Drug Delivery Formulation Revenue by Type (2017-2028)
    8.2 Asia Pacific Injectable Drug Delivery Formulation Market Size by Application
        8.2.1 Asia Pacific Injectable Drug Delivery Formulation Sales by Application (2017-2028)
        8.2.2 Asia Pacific Injectable Drug Delivery Formulation Revenue by Application (2017-2028)
    8.3 Asia Pacific Injectable Drug Delivery Formulation Market Size by Region
        8.3.1 Asia Pacific Injectable Drug Delivery Formulation Sales by Region (2017-2028)
        8.3.2 Asia Pacific Injectable Drug Delivery Formulation Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Injectable Drug Delivery Formulation Market Size by Type
        9.1.1 Latin America Injectable Drug Delivery Formulation Sales by Type (2017-2028)
        9.1.2 Latin America Injectable Drug Delivery Formulation Revenue by Type (2017-2028)
    9.2 Latin America Injectable Drug Delivery Formulation Market Size by Application
        9.2.1 Latin America Injectable Drug Delivery Formulation Sales by Application (2017-2028)
        9.2.2 Latin America Injectable Drug Delivery Formulation Revenue by Application (2017-2028)
    9.3 Latin America Injectable Drug Delivery Formulation Market Size by Country
        9.3.1 Latin America Injectable Drug Delivery Formulation Sales by Country (2017-2028)
        9.3.2 Latin America Injectable Drug Delivery Formulation Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Injectable Drug Delivery Formulation Market Size by Type
        10.1.1 Middle East and Africa Injectable Drug Delivery Formulation Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Injectable Drug Delivery Formulation Revenue by Type (2017-2028)
    10.2 Middle East and Africa Injectable Drug Delivery Formulation Market Size by Application
        10.2.1 Middle East and Africa Injectable Drug Delivery Formulation Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Injectable Drug Delivery Formulation Revenue by Application (2017-2028)
    10.3 Middle East and Africa Injectable Drug Delivery Formulation Market Size by Country
        10.3.1 Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Injectable Drug Delivery Formulation Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Becton, Dickinson and Company (US)
        11.1.1 Becton, Dickinson and Company (US) Corporation Information
        11.1.2 Becton, Dickinson and Company (US) Overview
        11.1.3 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Becton, Dickinson and Company (US) Recent Developments
    11.2 Baxter International Inc. (US)
        11.2.1 Baxter International Inc. (US) Corporation Information
        11.2.2 Baxter International Inc. (US) Overview
        11.2.3 Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Baxter International Inc. (US) Injectable Drug Delivery Formulation Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Baxter International Inc. (US) Recent Developments
    11.3 Gerresheimer AG (Germany)
        11.3.1 Gerresheimer AG (Germany) Corporation Information
        11.3.2 Gerresheimer AG (Germany) Overview
        11.3.3 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Gerresheimer AG (Germany) Recent Developments
    11.4 Pfizer, Inc. (US)
        11.4.1 Pfizer, Inc. (US) Corporation Information
        11.4.2 Pfizer, Inc. (US) Overview
        11.4.3 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Pfizer, Inc. (US) Recent Developments
    11.5 Schott AG (Germany)
        11.5.1 Schott AG (Germany) Corporation Information
        11.5.2 Schott AG (Germany) Overview
        11.5.3 Schott AG (Germany) Injectable Drug Delivery Formulation Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Schott AG (Germany) Injectable Drug Delivery Formulation Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Schott AG (Germany) Recent Developments
    11.6 Sandoz (Germany)
        11.6.1 Sandoz (Germany) Corporation Information
        11.6.2 Sandoz (Germany) Overview
        11.6.3 Sandoz (Germany) Injectable Drug Delivery Formulation Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Sandoz (Germany) Injectable Drug Delivery Formulation Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Sandoz (Germany) Recent Developments
    11.7 Teva Pharmaceutical Industries Ltd. (Israel)
        11.7.1 Teva Pharmaceutical Industries Ltd. (Israel) Corporation Information
        11.7.2 Teva Pharmaceutical Industries Ltd. (Israel) Overview
        11.7.3 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Teva Pharmaceutical Industries Ltd. (Israel) Recent Developments
    11.8 Eli Lilly and Company (US)
        11.8.1 Eli Lilly and Company (US) Corporation Information
        11.8.2 Eli Lilly and Company (US) Overview
        11.8.3 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Eli Lilly and Company (US) Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Injectable Drug Delivery Formulation Industry Chain Analysis
    12.2 Injectable Drug Delivery Formulation Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Injectable Drug Delivery Formulation Production Mode & Process
    12.4 Injectable Drug Delivery Formulation Sales and Marketing
        12.4.1 Injectable Drug Delivery Formulation Sales Channels
        12.4.2 Injectable Drug Delivery Formulation Distributors
    12.5 Injectable Drug Delivery Formulation Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Injectable Drug Delivery Formulation Industry Trends
    13.2 Injectable Drug Delivery Formulation Market Drivers
    13.3 Injectable Drug Delivery Formulation Market Challenges
    13.4 Injectable Drug Delivery Formulation Market Restraints
14 Key Findings in The Global Injectable Drug Delivery Formulation Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Injectable Drug Delivery Formulation Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Conventional Drug Delivery Formulations
    Table 3. Major Manufacturers of Novel Drug Delivery Formulations
    Table 4. Major Manufacturers of Long-acting Formulations
    Table 5. Global Injectable Drug Delivery Formulation Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Injectable Drug Delivery Formulation Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Injectable Drug Delivery Formulation Sales by Region (2017-2022) & (K Pcs)
    Table 8. Global Injectable Drug Delivery Formulation Sales Market Share by Region (2017-2022)
    Table 9. Global Injectable Drug Delivery Formulation Sales by Region (2023-2028) & (K Pcs)
    Table 10. Global Injectable Drug Delivery Formulation Sales Market Share by Region (2023-2028)
    Table 11. Global Injectable Drug Delivery Formulation Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Injectable Drug Delivery Formulation Revenue Market Share by Region (2017-2022)
    Table 13. Global Injectable Drug Delivery Formulation Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Injectable Drug Delivery Formulation Revenue Market Share by Region (2023-2028)
    Table 15. Global Injectable Drug Delivery Formulation Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 16. Global Injectable Drug Delivery Formulation Sales Share by Manufacturers (2017-2022)
    Table 17. Global Injectable Drug Delivery Formulation Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Injectable Drug Delivery Formulation Revenue Share by Manufacturers (2017-2022)
    Table 19. Injectable Drug Delivery Formulation Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 20. Global Injectable Drug Delivery Formulation Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Injectable Drug Delivery Formulation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Drug Delivery Formulation as of 2021)
    Table 22. Injectable Drug Delivery Formulation Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Injectable Drug Delivery Formulation Product Offered
    Table 24. Date of Manufacturers Enter into Injectable Drug Delivery Formulation Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)
    Table 27. Global Injectable Drug Delivery Formulation Sales by Type (2023-2028) & (K Pcs)
    Table 28. Global Injectable Drug Delivery Formulation Sales Share by Type (2017-2022)
    Table 29. Global Injectable Drug Delivery Formulation Sales Share by Type (2023-2028)
    Table 30. Global Injectable Drug Delivery Formulation Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Injectable Drug Delivery Formulation Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Injectable Drug Delivery Formulation Revenue Share by Type (2017-2022)
    Table 33. Global Injectable Drug Delivery Formulation Revenue Share by Type (2023-2028)
    Table 34. Injectable Drug Delivery Formulation Price by Type (2017-2022) & (USD/Pcs)
    Table 35. Global Injectable Drug Delivery Formulation Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 36. Global Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)
    Table 37. Global Injectable Drug Delivery Formulation Sales by Application (2023-2028) & (K Pcs)
    Table 38. Global Injectable Drug Delivery Formulation Sales Share by Application (2017-2022)
    Table 39. Global Injectable Drug Delivery Formulation Sales Share by Application (2023-2028)
    Table 40. Global Injectable Drug Delivery Formulation Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Injectable Drug Delivery Formulation Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Injectable Drug Delivery Formulation Revenue Share by Application (2017-2022)
    Table 43. Global Injectable Drug Delivery Formulation Revenue Share by Application (2023-2028)
    Table 44. Injectable Drug Delivery Formulation Price by Application (2017-2022) & (USD/Pcs)
    Table 45. Global Injectable Drug Delivery Formulation Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 46. North America Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)
    Table 47. North America Injectable Drug Delivery Formulation Sales by Type (2023-2028) & (K Pcs)
    Table 48. North America Injectable Drug Delivery Formulation Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Injectable Drug Delivery Formulation Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)
    Table 51. North America Injectable Drug Delivery Formulation Sales by Application (2023-2028) & (K Pcs)
    Table 52. North America Injectable Drug Delivery Formulation Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Injectable Drug Delivery Formulation Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Injectable Drug Delivery Formulation Sales by Country (2017-2022) & (K Pcs)
    Table 55. North America Injectable Drug Delivery Formulation Sales by Country (2023-2028) & (K Pcs)
    Table 56. North America Injectable Drug Delivery Formulation Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Injectable Drug Delivery Formulation Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)
    Table 59. Europe Injectable Drug Delivery Formulation Sales by Type (2023-2028) & (K Pcs)
    Table 60. Europe Injectable Drug Delivery Formulation Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Injectable Drug Delivery Formulation Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)
    Table 63. Europe Injectable Drug Delivery Formulation Sales by Application (2023-2028) & (K Pcs)
    Table 64. Europe Injectable Drug Delivery Formulation Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Injectable Drug Delivery Formulation Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Injectable Drug Delivery Formulation Sales by Country (2017-2022) & (K Pcs)
    Table 67. Europe Injectable Drug Delivery Formulation Sales by Country (2023-2028) & (K Pcs)
    Table 68. Europe Injectable Drug Delivery Formulation Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Injectable Drug Delivery Formulation Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)
    Table 71. Asia Pacific Injectable Drug Delivery Formulation Sales by Type (2023-2028) & (K Pcs)
    Table 72. Asia Pacific Injectable Drug Delivery Formulation Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Injectable Drug Delivery Formulation Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)
    Table 75. Asia Pacific Injectable Drug Delivery Formulation Sales by Application (2023-2028) & (K Pcs)
    Table 76. Asia Pacific Injectable Drug Delivery Formulation Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Injectable Drug Delivery Formulation Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Injectable Drug Delivery Formulation Sales by Region (2017-2022) & (K Pcs)
    Table 79. Asia Pacific Injectable Drug Delivery Formulation Sales by Region (2023-2028) & (K Pcs)
    Table 80. Asia Pacific Injectable Drug Delivery Formulation Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Injectable Drug Delivery Formulation Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)
    Table 83. Latin America Injectable Drug Delivery Formulation Sales by Type (2023-2028) & (K Pcs)
    Table 84. Latin America Injectable Drug Delivery Formulation Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Injectable Drug Delivery Formulation Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)
    Table 87. Latin America Injectable Drug Delivery Formulation Sales by Application (2023-2028) & (K Pcs)
    Table 88. Latin America Injectable Drug Delivery Formulation Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Injectable Drug Delivery Formulation Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Injectable Drug Delivery Formulation Sales by Country (2017-2022) & (K Pcs)
    Table 91. Latin America Injectable Drug Delivery Formulation Sales by Country (2023-2028) & (K Pcs)
    Table 92. Latin America Injectable Drug Delivery Formulation Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Injectable Drug Delivery Formulation Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Injectable Drug Delivery Formulation Sales by Type (2017-2022) & (K Pcs)
    Table 95. Middle East and Africa Injectable Drug Delivery Formulation Sales by Type (2023-2028) & (K Pcs)
    Table 96. Middle East and Africa Injectable Drug Delivery Formulation Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Injectable Drug Delivery Formulation Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Injectable Drug Delivery Formulation Sales by Application (2017-2022) & (K Pcs)
    Table 99. Middle East and Africa Injectable Drug Delivery Formulation Sales by Application (2023-2028) & (K Pcs)
    Table 100. Middle East and Africa Injectable Drug Delivery Formulation Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Injectable Drug Delivery Formulation Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2017-2022) & (K Pcs)
    Table 103. Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2023-2028) & (K Pcs)
    Table 104. Middle East and Africa Injectable Drug Delivery Formulation Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Injectable Drug Delivery Formulation Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Becton, Dickinson and Company (US) Corporation Information
    Table 107. Becton, Dickinson and Company (US) Description and Major Businesses
    Table 108. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 109. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Becton, Dickinson and Company (US) Recent Developments
    Table 111. Baxter International Inc. (US) Corporation Information
    Table 112. Baxter International Inc. (US) Description and Major Businesses
    Table 113. Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 114. Baxter International Inc. (US) Injectable Drug Delivery Formulation Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Baxter International Inc. (US) Recent Developments
    Table 116. Gerresheimer AG (Germany) Corporation Information
    Table 117. Gerresheimer AG (Germany) Description and Major Businesses
    Table 118. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 119. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Gerresheimer AG (Germany) Recent Developments
    Table 121. Pfizer, Inc. (US) Corporation Information
    Table 122. Pfizer, Inc. (US) Description and Major Businesses
    Table 123. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 124. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Pfizer, Inc. (US) Recent Developments
    Table 126. Schott AG (Germany) Corporation Information
    Table 127. Schott AG (Germany) Description and Major Businesses
    Table 128. Schott AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 129. Schott AG (Germany) Injectable Drug Delivery Formulation Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Schott AG (Germany) Recent Developments
    Table 131. Sandoz (Germany) Corporation Information
    Table 132. Sandoz (Germany) Description and Major Businesses
    Table 133. Sandoz (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 134. Sandoz (Germany) Injectable Drug Delivery Formulation Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Sandoz (Germany) Recent Developments
    Table 136. Teva Pharmaceutical Industries Ltd. (Israel) Corporation Information
    Table 137. Teva Pharmaceutical Industries Ltd. (Israel) Description and Major Businesses
    Table 138. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 139. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Teva Pharmaceutical Industries Ltd. (Israel) Recent Developments
    Table 141. Eli Lilly and Company (US) Corporation Information
    Table 142. Eli Lilly and Company (US) Description and Major Businesses
    Table 143. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 144. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Eli Lilly and Company (US) Recent Developments
    Table 146. Key Raw Materials Lists
    Table 147. Raw Materials Key Suppliers Lists
    Table 148. Injectable Drug Delivery Formulation Distributors List
    Table 149. Injectable Drug Delivery Formulation Customers List
    Table 150. Injectable Drug Delivery Formulation Market Trends
    Table 151. Injectable Drug Delivery Formulation Market Drivers
    Table 152. Injectable Drug Delivery Formulation Market Challenges
    Table 153. Injectable Drug Delivery Formulation Market Restraints
    Table 154. Research Programs/Design for This Report
    Table 155. Key Data Information from Secondary Sources
    Table 156. Key Data Information from Primary Sources
List of Figures
    Figure 1. Injectable Drug Delivery Formulation Product Picture
    Figure 3. Global Injectable Drug Delivery Formulation Market Share by Type in 2021 & 2028
    Figure 3. Conventional Drug Delivery Formulations Product Picture
    Figure 4. Novel Drug Delivery Formulations Product Picture
    Figure 5. Long-acting Formulations Product Picture
    Figure 6. Global Injectable Drug Delivery Formulation Market Share by Application in 2021 & 2028
    Figure 7. Autoimmune Diseases
    Figure 8. Hormonal Disorders
    Figure 9. Oncology
    Figure 10. Orphan Diseases
    Figure 11. Others
    Figure 12. Injectable Drug Delivery Formulation Report Years Considered
    Figure 13. Global Injectable Drug Delivery Formulation Sales 2017-2028 (K Pcs)
    Figure 14. Global Injectable Drug Delivery Formulation Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Injectable Drug Delivery Formulation Revenue 2017-2028 (US$ Million)
    Figure 16. Global Injectable Drug Delivery Formulation Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Injectable Drug Delivery Formulation Sales Market Share by Region (2017-2022)
    Figure 18. Global Injectable Drug Delivery Formulation Sales Market Share by Region (2023-2028)
    Figure 19. North America Injectable Drug Delivery Formulation Sales YoY (2017-2028) & (K Pcs)
    Figure 20. North America Injectable Drug Delivery Formulation Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Injectable Drug Delivery Formulation Sales YoY (2017-2028) & (K Pcs)
    Figure 22. Europe Injectable Drug Delivery Formulation Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Injectable Drug Delivery Formulation Sales YoY (2017-2028) & (K Pcs)
    Figure 24. Asia-Pacific Injectable Drug Delivery Formulation Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Injectable Drug Delivery Formulation Sales YoY (2017-2028) & (K Pcs)
    Figure 26. Latin America Injectable Drug Delivery Formulation Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Injectable Drug Delivery Formulation Sales YoY (2017-2028) & (K Pcs)
    Figure 28. Middle East & Africa Injectable Drug Delivery Formulation Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Injectable Drug Delivery Formulation Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Injectable Drug Delivery Formulation in the World: Market Share by Injectable Drug Delivery Formulation Revenue in 2021
    Figure 31. Global Injectable Drug Delivery Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2028)
    Figure 33. Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2017-2028)
    Figure 34. Global Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2028)
    Figure 35. Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2017-2028)
    Figure 36. North America Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2028)
    Figure 37. North America Injectable Drug Delivery Formulation Revenue Market Share by Type (2017-2028)
    Figure 38. North America Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2028)
    Figure 39. North America Injectable Drug Delivery Formulation Revenue Market Share by Application (2017-2028)
    Figure 40. North America Injectable Drug Delivery Formulation Sales Share by Country (2017-2028)
    Figure 41. North America Injectable Drug Delivery Formulation Revenue Share by Country (2017-2028)
    Figure 42. U.S. Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2028)
    Figure 45. Europe Injectable Drug Delivery Formulation Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2028)
    Figure 47. Europe Injectable Drug Delivery Formulation Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Injectable Drug Delivery Formulation Sales Share by Country (2017-2028)
    Figure 49. Europe Injectable Drug Delivery Formulation Revenue Share by Country (2017-2028)
    Figure 50. Germany Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 51. France Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Injectable Drug Delivery Formulation Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Injectable Drug Delivery Formulation Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Injectable Drug Delivery Formulation Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Injectable Drug Delivery Formulation Revenue Share by Region (2017-2028)
    Figure 61. China Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 64. India Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Injectable Drug Delivery Formulation Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Injectable Drug Delivery Formulation Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Injectable Drug Delivery Formulation Sales Share by Country (2017-2028)
    Figure 76. Latin America Injectable Drug Delivery Formulation Revenue Share by Country (2017-2028)
    Figure 77. Mexico Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Injectable Drug Delivery Formulation Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Injectable Drug Delivery Formulation Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Injectable Drug Delivery Formulation Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Injectable Drug Delivery Formulation Revenue Share by Country (2017-2028)
    Figure 86. Turkey Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 88. UAE Injectable Drug Delivery Formulation Revenue (2017-2028) & (US$ Million)
    Figure 89. Injectable Drug Delivery Formulation Value Chain
    Figure 90. Injectable Drug Delivery Formulation Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Becton, Dickinson and Company (US)
Baxter International Inc. (US)
Gerresheimer AG (Germany)
Pfizer, Inc. (US)
Schott AG (Germany)
Sandoz (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (US)
Frequently Asked Questions
Injectable Drug Delivery Formulation report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Injectable Drug Delivery Formulation report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Injectable Drug Delivery Formulation report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Integrin Beta 3

Integrin Beta 3 market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

Mucin 1

Mucin 1 market is segmented by Type and by Application. Players, stakeholders, and other particip ... Read More